Growth in Preterm Birth and Prenatal Testing Market Accelerated by Rising Awareness of Fetal Healthcare

The global Noninvasive Prenatal Testing Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.

Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the Genesis Genetics (CooperSurgical, Inc.), Centogene N.V., Eurofins LifeCodexx GmbH, F. Hoffmann-La Roche Ltd (Ariosa Diagnostics), Progenity, Inc., Laboratory Corp. of America Holdings, Natera, Inc., Illumina, Inc. (Verinata Health, Inc.), MedGenome Labs Ltd., Myriad Women’s Health, Inc. (Myriad Genetics Inc/Counsyl, Inc.), QiagenQuest Diagnostics, Inc.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Noninvasive Prenatal Testing Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/noninvasive-prenatal-testing-market/download-sampleMarket SegmentationThe broad Noninvasive Prenatal Testing market has been sub-grouped into the Gestation period, Risk Type, Method, Technology, Product, End-User, and region.

The report studies these subsets with respect to the geographical segmentation.

The strategists can gain a detailed insight and devise appropriate strategies to target specific market.

The growing awareness about the advantages of advanced testing procedures is projected to further stimulate the market growth in the estimated timeframe.

Moreover, the rising corrections and improvements in the reimbursement scenario in prenatal testing are further predicted to bolster the market growth in the estimated years.

Additionally, the augmenting incidences of miscarriages globally are also adding traction to market growth.To get leading market solutions, visit the link below: https://www.emergenresearch.com/industry-report/prenatal-testing-marketMajor players in the global market include Quest Diagnostics, Natera, Inc., GeneDx, Inc., Illumina, Inc., Prenatal Paternities Inc., Ravgen Inc., Ariosa Diagnostics, Inc., Counsyl, Inc., LabCorp, and Eurofins NTD Inc., among others.Prenatal Testing Market Solution Insight:The ultrasound sub-segment is projected to expand significantly over the projected timespan, registering a CAGR of 13.2%.

The growth of the segment can be accredited to the secure and pain-free attributes of ultrasound prenatal testing procedures.

The method utilizes sound waves to produce images that provide insights into the baby’s position and condition.The Prenatal Testing Market is expected to be valued at USD 8.08 Billion by 2027 from USD 3.23 Billion in 2019, registering a CAGR of 12.9% through the forecast period.Method Outlook (Revenue, USD Billion; 2017-2027)Blood or SalivaUltrasoundUrineAmniocentesisPercutaneous umbilical blood samplingChorionic villus samplingTest Type Outlook (Revenue, USD Billion; 2017-2027)Non-InvasiveInvasiveRegional Analysis of the Prenatal Testing Market Includes:North America (U.S., Canada)Europe (U.K., Italy, Germany, France, Rest of EU)Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)Latin America (Chile, Brazil, Argentina, Rest of Latin America)Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA)Thank you for reading our report.

To request a customization or for further inquiries, kindly get in touch with us.

Prenatal Testing Market enables us to detect the problems associated with the pregnancy.

Prenatal genetic testing is done to know the birth defects such as Down syndrome, Trisomy 13, Trisomy 18 and others that are associated with genetic disorder of an unborn child before birth or during pregnancy.According to World Health Organization, about 2%-5% of all live births, account for up to 30% of pediatric hospital admissions and cause about 50% of childhood deaths in industrialized countries, almost more than half of these deaths could have been avoided with the availability of proper medical equipment and devices for healthcare procedures.

This significant number is expected to act as a driver to the market growth.Prenatal Genetic Testing Market is expected to rise gradually to an estimated value of USD 92.32 billion by 2026, registering a CAGR of 29.2% in the forecast period of 2019-2026 with the annual sales of USD 11.89 billion in year 2018.Prenatal Genetic Testing Market report has been formulated with a meticulous market analysis that is performed by a team of industry experts, skilful analysts, dynamic forecasters and knowledgeable researchers.

The market study of this report estimates the market status, market share, growth rate, future trends, market drivers, opportunities and challenges, risks and entry barriers, sales channels, and distributors.

This Prenatal Genetic Testing Market report is the best source to bring about unparalleled insights and acquaintance of the best market opportunities into the relevant markets.

Additionally, businesses can accomplish great benefits with this information to come to a decision on their production and marketing strategies.Click Here to Get Sample Report of Prenatal Genetic Testing Market @https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-prenatal-genetic-testing-marketMarket Drivers and Restraints:Increasing prevalence of genetic diseases such as down syndrome, edward syndrome and patau syndrome and rising awareness among population.Rising demand for prenatal testing for identifying genetic abnormalities.Increasing approaches for novel diagnostic techniques and tools.High test costs make it unaffordable for the middle class people.High skilled professionals are required.The major players covered in the Prenatal Genetic Testing MarketFew of the major competitors currently working in the dosage cups market are Bio-Rad Laboratories Inc. (US), Agilent Technologies Inc. (US), Illumina, Inc (US), Natera Inc. (US) Abbott (US), Cepheid (US), ELITech Group (France), Autogenomics (US),   Sequenom (US), GeneDx (US), 23andMe, Inc. (US), Ambry Genetics (US), Invitae Corporation (US), Pathway Genomics (US), Progenity, Inc. (US), and few among others.Major TOC Of The ReportChapter One: Prenatal Genetic Testing Market OverviewChapter Two: Manufacturers ProfilesChapter Three:  Global Prenatal Genetic Testing Market  Competition, by PlayersChapter Four: Global Prenatal Genetic Testing Market Size by RegionsChapter Five: North America Prenatal Genetic Testing Market Revenue by CountriesChapter Six: Europe Prenatal Genetic Testing Market Revenue by CountriesChapter Seven: Asia-Pacific Prenatal Genetic Testing Market Revenue by CountriesChapter Eight: South America Prenatal Genetic Testing Market Revenue by CountriesNew Business Strategies, Challenges & Policies are mentioned in Table of Content, Get Download Detailed TOC athttps://www.databridgemarketresearch.com/toc/?dbmr=global-prenatal-genetic-testing-marketKey Report HighlightsComprehensive pricing analysis based on different product types and regional segmentsMarket size data in terms of revenue and sales volumeDeep insights about regulatory and investment scenarios of the Prenatal Genetic Testing Market    Analysis of market effect factors and their impact on the forecast and outlook of the Prenatal Genetic Testing Market    The detailed assessment of the vendor landscape and leading companies to help understand the level of competition in the Prenatal Genetic Testing Market    A roadmap of growth opportunities available in the Prenatal Genetic Testing Market    with the identification of key factorsThe exhaustive analysis of various trends of the Prenatal Genetic Testing Market    to help identify market developmentsAccess Full Report @  https://www.databridgemarketresearch.com/reports/global-prenatal-genetic-testing-marketKey Questions Answered in Report:What is the key to the Prenatal Genetic Testing Market?What will the Prenatal Genetic Testing Market Demand and what will be Growth?What are the latest opportunities for Prenatal Genetic Testing Market in the future?What are the strengths of the key players?Browse Related Reports@Mass Spectrometry Software MarketMedication Delivery Systems MarketPDX Models MarketAbout Us:Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches.

The global preterm birth prevention and management market surpassed the valuation of US$ 1 Bn in 2019, with growth projected to see a robust CAGR of more than 9% through 2029.

The preterm birth prevention drugs industry is observing a substantial surge in number of FDA-approved new generic copies of blockbuster drugs every year.

This can be primarily attributed to favorable government policy framework and demographics, orphan drug designations, adoption of new combination therapies, and complications in the selection of one line of therapy.Key Takeaways of the StudyDevelopment of higher complexity specific portfolios and consistent focus on areas of strength while working pipelines are the cornerstone for success in the preterm birth prevention market space.Ensuring preterm interventions and research given proportional focus, so funding is aligned with health burden to curb the mortality rateMakena, with various approvals for the treatment of preterm birth in potential female patient pool, contributed to the dominance of the progesterone therapy segment by therapy type in 2018 and continue to do so during the forecast period.Highly effective therapies with cost advantage over are expected to generate significant revenue in the long run.Majority of the global preterm birth cases have not been directed towards preterm diagnostic leading to higher mortality rates and complicationsSale of Hydroxyprogesterone over antihypertensive drugs such as Nifedipine, and labetalol in the global preterm birth prevention and management market has increased drastically owing to quicker onset of action and higher efficacy.The demand from high preterm birth rate countries, development of new drug entity, loss of exclusivity in hydroxyprogesterone, and growth strategies based on tie up with distribution channel partners are projected to offer new growth opportunities for the preterm birth prevention and management market.Request For Report Sample @ https://www.futuremarketinsights.com/reports/sample/rep-gb-6457Launch of Cost-effective Therapies Bodes Well for MarketNew revenue opportunities in developed economies, and orphan drug designation by FDA are contributing significantly towards the launch of cost-effective therapies.

A few other factors assisting the growth of preterm birth prevention and management market include adoption of preterm diagnostic tests and the economic burden of premature birth on the system.Frequent drug shortages and unavailability of life-saving formulations in many parts of the country, growing initiatives by government and manufacturers for supply of life-saving preterm birth drugs, particularly in low income and developing countries, are driving the market growth.Strategic Acquisitions by Key Players to Widen Regional PresenceThe leading players in the preterm birth prevention and management market such as AMAG Pharmaceuticals, Pfizer Inc., and Mylan, are concentrating on organic revenue growth and commercial expansions by mergers and distribution agreements and capturing the untapped potential of the preterm birth prevention and management market.In 2019, AMAG Pharmaceuticals, Inc. a largest preterm birth prevention and management drug manufacturer announced the completion of acquisition of Perosphere Pharmaceuticals Inc., a private biopharmaceutical firm.

This acquisition further strengthened AMAG Pharmaceuticals hold of preterm birth prevention and management business with addition of heparin therapyAMAG acquired the global rights to R and marketing of digoxin immune Fab, a drug used to treat severe preeclampsia in pregnant women from Velo Bio, LLC.More Valuable Insights on Preterm birth prevention and management MarketFuture Market Insights brings the comprehensive research report on forecasted revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the segments from 2014 to 2029.

The global preterm birth prevention and management market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.The study provide compelling insights on preterm birth prevention and management market on basis of therapy type (progesterone therapy, corticosteroid therapy, tocolytics therapy, antihypertensive therapy, magnesium sulfate therapy, heparin prophylaxis therapy, low-dose aspirin therapy, and antibiotics therapy) and by route of administration (Oral, Parenteral, and Vaginal) , and by patient type (prior spontaneous PTB, preeclampsia, short cervix, chronic hypertension, insulin-dependent, twins, antiphospholipid antibody syndrome, and others) and by distribution channel (hospital pharmacies, retail pharmacies, drug stores, and mail order pharmacies), across seven major regions.Speak to Analyst, Questions Related To Report @ https://www.futuremarketinsights.com/ask-question/rep-gb-6457Reasons to Buy the reportWe provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players.Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include.The report includes accurate analysis of the market and the current developing trends affecting the growth.

Recently published a report entitled Preterm Birth And PROM Testing Market projected till 2026, added by Value Market Research, covers key players along with their market share and strategic development adopted by them.

Further, the report provides market size, share, trends, outlook and forecast based on historical data coupled with drivers, restraints, and opportunities.The entire preterm birth and PROM testing market has been sub-categorized into test type and end-user.

The report provides an analysis of these subsets with respect to the geographical segmentation.

This research study will keep marketer informed and helps to identify the target demographics for a product or service.Request a FREE Sample Copy of Preterm Birth And PROM Testing Market Report with Full TOC At: https://www.valuemarketresearch.com/contact/preterm-birth-and-prom-testing-market/download-sampleBy Test TypePreterm Birth TestsPelvic ExamUltrasoundUterine MonitoringBiomarkersPROM TestsNitrazine TestFerning TestPoolingUltrasoundFetal Fibronectin TestBiomarker TestsOthersBy ApplicationHospitalsDiagnostic LaboratoriesOthersThe research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.

The major players in the preterm birth and PROM testing market include Abbott Laboratories, Biosynex, Clinical Innovations, LLC, Cooper Companies, Inc., Hologic, Inc., IQ Products, Medix Biochemica, NX Prenatal, Inc., QIAGEN, and Sera Prognostics, Inc.

This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.This section covers regional segmentation which accentuates on current and future demand for preterm birth and PROM testing market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa.

A developing baby undergoes through crucial growth process throughout the pregnancy including the final month.

If babies are born too early than the desired time period of pregnancy, it creates high chances the disability for the baby.

extremely preterm (less than 28 weeks), very preterm (28 to 32 weeks), moderate to late preterm (32 to 37 weeks).

Stringent regulatory scenario for the drug approval to treat the pregnant women will deter the growth of preterm birth prevention and management market to some extent.

According to WHO, the rate of preterm birth ranges from 5% to 18% of babies born across the 184 countries throughout the globe.

Among all the preterm birth, 60% of cases happen only in South Asia and Africa but preterm birth is actually a global issue.

Prenatal and New-born Genetic Testing Market:WiseGuyReports.com adds “Global Prenatal and New-born Genetic Testing Market Research Report 2020 Analysis and Forecast 2026” reports to its database.Executive SummaryGlobal Prenatal and New-born Genetic Testing Market is valued approximately USD 13.98 Billion in 2019 and is anticipated to grow with a healthy growth rate of more than 11.9% over the forecast period 2019-2026.

The test is conducted during time interval of pregnancy to determine the health of the fetus at an early stage and helps in identifying various genetic and chromosomal anomalies such as birth defects, gene mutations and cystic fibrosis etc.

Hence, rapid growth in birth of abnormal kids along with rising cases of new-born babies with genetic disorder is expected to drive the growth of market over the forecast years.

Also, as per the Centers of Diseases Control, birth defects affect one in every 33 babies (about 3% of all babies) born in the United States each year and is a leading cause of infant deaths, accounting for 20% of all infant deaths.

Thus, increase in cases of birth defects in newborn baby and remarkable application of Prenatal and New-born Genetic Testing to identify it at an early stage are the factors accelerating the growth of market over the forecast years.

However, lack of advanced infrastructure and skilled labor in developing region are the factors that hamper the growth of market.Request Free Sample Report @ https://www.wiseguyreports.com/sample-request/5278137-global-prenatal-and-new-born-genetic-testing-marketThe regional analysis of global Prenatal and New-born Genetic Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World.